menu

Autism Spectrum Disorder Treatment Market

Schedule Call

Autism Spectrum Disorder Treatment Market

Autism Spectrum Disorder Treatment Market by Drug Therapy (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medications, and Others) by Disease (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), by Age Group (Children and Adults) and by Distribution Channel (Hospital Pharmacies, Drugs Stores & Retail Pharmacies, and Online Pharmacies) - Global Outlook & Forecast 2022-2030

GR - 176655 Category: Pharmaceuticals

Number of pages: 100  |  Report Format: PDF  |  Published date: 14 October, 2022

Historical Years – 2020  |  Base Year – 2021  |  Forecasted Years – 2022-2030


Autism Spectrum Disorder Treatment Market Scope

Report Attribute

Details

Market size value in 2021

US$ 6.91 billion

Revenue forecast in 2030

US$ 11.89 billion

Growth Rate

CAGR of 6.2% from 2022 to 2030

Base year for estimation

2021

Forecast period

2022-2030

Segments covered

Drug therapy, disease, age group, distribution channel, and region.

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Report Overview

The global autism spectrum disorder treatment market was pegged at US$ 6.91 billion in 2021 and is expected to witness a CAGR of 6.2% during the forecast period. 

Market Fundamentals 

Autism spectrum disorder is a neurological disorder that causes problems with social communication and interaction, and some autism spectrum disorder patients may experience a lack of interest, repetitive behaviors, sleep disorders, and delayed speech development. Autism spectrum disorder can be diagnosed at any age, but it mostly appears in the first two years of age. Autism spectrum is a lifelong condition, and no treatment is available to cure the disorder. However, healthcare providers frequently use various medications to treat a specific behavior, such as self-injury or aggression. Minimizing a symptom allows the autistic person to concentrate on other things, such as learning and communication.

[6564534]

Market Dynamics

The global autism spectrum disorder treatment market is mainly driven by increasing investment in research and development for treating autism spectrum disorder and increasing government initiatives for drug development. Additionally, increasing awareness of the disease and rising funding from NGOs contribute to the growth of the global autism spectrum disorder treatment market. Moreover, the increasing prevalence of autism spectrum disorder and advanced diagnostic technology fuel the global autism spectrum disorder market. However, the lack of approved drugs, the high cost, and the heavy investment required for research and development are hindering the growth of the global autism spectrum disorder treatment market. 

Market Ecosystem

The global autism spectrum disorder treatment market has been analyzed from five perspectives: Drug therapy, disease, age group, distribution channel, and region. 

Autism Spectrum Disorder Treatment Market by Drug Therapy 

[33423432]

Based on drug therapy, the global autism spectrum disorder treatment market has been segmented into antipsychotic drugs, selective serotonin reuptake inhibitors, stimulants, sleep medications, and others. Stimulant drug therapy is leading the global autism spectrum disorder treatment market owing increasing use of stimulants, as it does not change the core characteristics of autism. It helps autistic children with attention deficiency and hyperactivity disorder. Antipsychotic drugs are also expected to show the highest growth during the forecast period owing to the increasing use of antipsychotic drugs for treating irritability and other symptoms.

Autism Spectrum Disorder Treatment Market by Disease

Based on diseases, the global autism spectrum disorder treatment market is segmented into autistic disorder, Asperger syndrome, pervasive developmental disorder, and others. Autistic disorder leads the global market owing to the high prevalence and growing awareness of autism disorder. Additionally, increasing government and NGOs initiative for creating awareness and providing treatment is contributing to the growth of the global autistic disorder treatment market.

Autism Spectrum Disorder Treatment Market by Age Group 

The global autism spectrum disorder treatment market has been segmented based on age group into children and adults. The adult segment is leading the global autism spectrum market owing to increasing cost-effective therapies for adults and the increasing prevalence of autism. Additionally, increasing research and development for adult autism spectrum drug treatment are contributing to the growth of the segment. 

Autism Spectrum Disorder Treatment Market by Distribution Channel 

Based on distribution channels, the global autism spectrum disorder treatment market has been segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. Hospital pharmacies are leading the global autism spectrum disorder market owing to the increasing number of hospital pharmacies and increasing patient footfall for diagnosis and treatment. Additionally, the adoption of novel treatments and therapy contributes to the growth of the autism spectrum disorder treatment market.

Autism Spectrum Disorder Treatment Market by Region

Based on region, the global autism spectrum disorder treatment market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the global autism spectrum disorder treatment market regarding revenue share. The large share of North America in the global market can be attributed to growing prevalence, growing awareness about autism, and improving diagnostic techniques. Additionally, developed infrastructure and advanced healthcare systems are contributing to the growth of the autism spectrum disorder market. 

Competitive Landscape

Some prominent players operating in the global autism spectrum disorder treatment market are 

  • Alembic Pharmaceuticals Limited
  • Aurobindo Pharma Ltd. 
  • Curemark, LLC
  • F. Hoffmann-La Roche Ltd. 
  • H. Lundbeck A/S
  • Janssen Pharmaceuticals, Inc. 
  • Otsuka Holdings Co. Ltd.
  • PaxMedica
  • Teva Pharmaceutical Industries Ltd. 
  • Yamo Pharmaceuticals 

Frequently Asked Questions About This Report

Growing investment in research and development for the treatment of autism spectrum disorder and increasing government initiatives for drug development are key driving factors for the global autism spectrum disorder treatment market.

The estimated market size of the global autism spectrum disorder treatment market US$ 11.89 billion in 2030.

The expected CAGR for the global autism spectrum disorder treatment market is 6.2% during the forecast period from 2022 to 2030.

North America is the key growth region in the global autism spectrum disorder treatment market.

Alembic Pharmaceuticals Limited, Aurobindo Pharma Ltd., Curemark, LLC, F. Hoffmann-La Roche Ltd, H. Lundbeck A/S, Janssen Pharmaceuticals, Inc., Otsuka Holdings Co. Ltd., PaxMedica, Teva Pharmaceutical Industries Ltd. and Yamo Pharmaceuticals among others.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL AUTISM SPECTRUM DISORDER TREATMENT MARKET - ANALYSIS & FORECAST, BY DRUG THERAPY
    1. Antipsychotic Drug Therapy
    2. Sleep Medications
    3. Selective Serotonin Reuptake Inhibitors
    4. Stimulants
    5. Others
  6. GLOBAL AUTISM SPECTRUM DISORDER TREATMENT MARKET - ANALYSIS & FORECAST, BY DISEASE
    1. Asperger Syndrome
    2. Pervasive Developmental Disorder
    3. Autistic Disorder
    4. Others
  7. GLOBAL AUTISM SPECTRUM DISORDER TREATMENT MARKET - ANALYSIS & FORECAST, BY AGE GROUP
    1. Children 
    2. Adults
  8. GLOBAL AUTISM SPECTRUM DISORDER TREATMENT MARKET - ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
    1. Hospital Pharmacies
    2. Drug Therapies Stores & Retail Pharmacies
    3. Online Pharmacies
  9. GLOBAL AUTISM SPECTRUM DISORDER TREATMENT MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Autism Spectrum Disorder Treatment Market
      1. North America Autism Spectrum Disorder Treatment Market, by Drug Therapy
      2. North America Autism Spectrum Disorder Treatment Market, by Disease
      3. North America Autism Spectrum Disorder Treatment Market, by Age Group
      4. North America Autism Spectrum Disorder Treatment Market, by Distribution Channel
      5. North America Autism Spectrum Disorder Treatment Market, by Region
        1. U.S.
          1. U.S. Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. U.S. Autism Spectrum Disorder Treatment Market, by Disease
          3. U.S. Autism Spectrum Disorder Treatment Market, by Age Group
          4. U.S. Autism Spectrum Disorder Treatment Market, by Distribution Channel
        2. Canada
          1. Canada Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. Canada Autism Spectrum Disorder Treatment Market, by Disease
          3. Canada Autism Spectrum Disorder Treatment Market, by Age Group
          4. Canada Autism Spectrum Disorder Treatment Market, by Distribution Channel
    2. Europe Autism Spectrum Disorder Treatment Synthesis Market
      1. Europe Autism Spectrum Disorder Treatment Market, by Drug Therapy
      2. Europe Autism Spectrum Disorder Treatment Market, by Disease
      3. Europe Autism Spectrum Disorder Treatment Market, by Age Group
      4. Europe Autism Spectrum Disorder Treatment Market, by Distribution Channel
      5. Europe Autism Spectrum Disorder Treatment Market, by Region
        1. Germany
          1. Germany Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. Germany Autism Spectrum Disorder Treatment Market, by Disease
          3. Germany Autism Spectrum Disorder Treatment Market, by Age Group
          4. Germany Autism Spectrum Disorder Treatment Market, by Distribution Channel
        2. U.K
          1. U.K Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. U.K Autism Spectrum Disorder Treatment Market, by Disease
          3. U.K Autism Spectrum Disorder Treatment Market, by Age Group
          4. U.K Autism Spectrum Disorder Treatment Market, by Distribution Channel
        3. France
          1. France Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. France Autism Spectrum Disorder Treatment Market, by Disease
          3. France Autism Spectrum Disorder Treatment Market, by Age Group
          4. France Autism Spectrum Disorder Treatment Market, by Distribution Channel
        4. Spain
          1. Spain Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. Spain Autism Spectrum Disorder Treatment Market, by Disease
          3. Spain Autism Spectrum Disorder Treatment Market, by Age Group
          4. Spain Autism Spectrum Disorder Treatment Market, by Distribution Channel
        5. Italy
          1. Italy Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. Italy Autism Spectrum Disorder Treatment Market, by Disease
          3. Italy Autism Spectrum Disorder Treatment Market, by Age Group
          4. Italy Autism Spectrum Disorder Treatment Market, by Distribution Channel
        6. Rest of Europe 
          1. Rest of Europe Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. Rest of Europe Autism Spectrum Disorder Treatment Market, by Disease
          3. Rest of Europe Autism Spectrum Disorder Treatment Market, by Age Group 
          4. Rest of Europe Autism Spectrum Disorder Treatment Market, by Distribution Channel
    3. Asia Pacific Autism Spectrum Disorder Treatment Market
      1. Asia Pacific Autism Spectrum Disorder Treatment Market, by Drug Therapy
      2. Asia Pacific Autism Spectrum Disorder Treatment Market, by Disease
      3. Asia Pacific Autism Spectrum Disorder Treatment Market, by Age Group
      4. Asia Pacific Autism Spectrum Disorder Treatment Market, by Distribution Channel
      5. Asia Pacific Autism Spectrum Disorder Treatment Market, by Region
        1. China
          1. China Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. China Autism Spectrum Disorder Treatment Market, by Disease
          3. China Autism Spectrum Disorder Treatment Market, by Age Group
          4. China Autism Spectrum Disorder Treatment Market, by Distribution Channel
        2. Japan
          1. Japan Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. Japan Autism Spectrum Disorder Treatment Market, by Disease
          3. Japan Autism Spectrum Disorder Treatment Market, by Age Group
          4. Japan Autism Spectrum Disorder Treatment Market, by Distribution Channel
        3. India
          1. India Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. India Autism Spectrum Disorder Treatment Market, by Disease
          3. India Autism Spectrum Disorder Treatment Market, by Age Group
          4. India Autism Spectrum Disorder Treatment Market, by Distribution Channel
        4. South Korea
          1. South Korea Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. South Korea Autism Spectrum Disorder Treatment Market, by Disease
          3. South Korea Autism Spectrum Disorder Treatment Market, by Age Group
          4. South Korea Autism Spectrum Disorder Treatment Market, by Distribution Channel
        5. Australia
          1. Australia Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. Australia Autism Spectrum Disorder Treatment Market, by Disease
          3. Australia Autism Spectrum Disorder Treatment Market, by Age Group
          4. Australia Autism Spectrum Disorder Treatment Market, by Distribution Channel
        6. Rest of Asia Pacific
          1. Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. Rest of Asia pacific Autism Spectrum Disorder Treatment Market, by Disease
          3. Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Age Group
          4. Rest of Asia Pacific Autism Spectrum Disorder Treatment Market, by Distribution Channel
    4. Middle East & Africa Autism Spectrum Disorder Treatment Market
      1. Middle East & Africa Autism Spectrum Disorder Treatment Market, by Drug Therapy
      2. Middle East & Africa Autism Spectrum Disorder Treatment Market, by Disease
      3. Middle East & Africa Autism Spectrum Disorder Treatment Market, by Age Group
      4. Middle East & Africa Autism Spectrum Disorder Treatment Market, by Distribution Channel
      5. Middle East & Africa Autism Spectrum Disorder Treatment Market, by Region
        1. GCC Countries
          1. GCC countries Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. GCC countries Autism Spectrum Disorder Treatment Market Analysis by Disease
          3. GCC countries Autism Spectrum Disorder Treatment Market Analysis by Age Group
          4. GCC countries Autism Spectrum Disorder Treatment Market Analysis by Distribution Channel
        2. South Africa
          1. Africa Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. Africa Autism Spectrum Disorder Treatment Market Analysis by Disease
          3. Africa Autism Spectrum Disorder Treatment Market Analysis by Age Group
          4. Africa Autism Spectrum Disorder Treatment Market Analysis by Distribution Channel
        3. Turkey
          1. Turkey Autism Spectrum Disorder Treatment Market, by Drug Therapy
          2. Turkey Autism Spectrum Disorder Treatment Market Analysis by Disease
          3. Turkey Autism Spectrum Disorder Treatment Market Analysis by Age Group
          4. Turkey Autism Spectrum Disorder Treatment Market Analysis by Distribution Channel
        4. Rest of Middle East and Africa
    5. Latin America Autism Spectrum Disorder Treatment Market
      1. Latin America Autism Spectrum Disorder Treatment Market, by Drug Therapy 
      2. Latin America Autism Spectrum Disorder Treatment Market, by Disease
      3. Latin America Autism Spectrum Disorder Treatment Market, by Age Group
      4. Latin America World Autism Spectrum Disorder Treatment Market, by Distribution Channel
    6. Rest of the World Autism Spectrum Disorder Treatment Market
      1. Rest of the World Autism Spectrum Disorder Treatment Market, by Drug Therapy
      2. Rest of the World Autism Spectrum Disorder Treatment Market, by Disease
      3. Rest of the World Autism Spectrum Disorder Treatment Market, by Age Group
      4. Rest of the World Autism Spectrum Disorder Treatment Market, by Distribution Channel
      5. Rest of the World Autism Spectrum Disorder Treatment Market, by Region
  10. COMPANY PROFILES         
    1. Alembic Pharmaceuticals Limited
      1. Business Snapshot 
      2. Drug Therapy Offered
      3. Financial Details
      4. Strategic Development
    2. Aurobindo Pharma Ltd. 
    3. Curemark, LLC
    4. F. Hoffmann-La Roche Ltd 
    5. H. Lundbeck A/S
    6. Janssen Pharmaceuticals, Inc. 
    7. Otsuka Holdings Co. Ltd.
    8. PaxMedica
    9. Teva Pharmaceutical Industries Ltd. 
    10. Yamo Pharmaceuticals

*Insights on financial performance are subject to the availability of information in the public domain


Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.

Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.

GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.

Related Report

sans

Snehal Deshmukh

Principle Consultant

Speak to analyst